{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:33:39Z","timestamp":1746185619915,"version":"3.37.3"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["ETIUDA\/2015\/16\/T\/NZ7\/00052"],"award-info":[{"award-number":["ETIUDA\/2015\/16\/T\/NZ7\/00052"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["PO FESR 2007\/2013"],"award-info":[{"award-number":["PO FESR 2007\/2013"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T23:22:48Z","timestamp":1466896968000},"page":"251-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain"],"prefix":"10.1016","volume":"111","author":[{"given":"Natalia","family":"Malek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Pajak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Kucharczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Przewlocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Starowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.06.012_bib0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.111.180257","article-title":"Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain","volume":"338","author":"Ahn","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.06.012_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainresrev.2008.12.003","article-title":"Targeting CB2 receptors and the endocannabinoid system for the treatment of pain","volume":"60","author":"Anand","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.phrs.2016.06.012_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.brainresbull.2005.07.001","article-title":"TRPV1 desensitisation and endogenous vanilloid involvement in the enhanced analgesia induced by capsaicin in inflamed tissues","volume":"67","author":"Baamonde","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2016.06.012_bib0020","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1111\/bph.12850","article-title":"Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling","volume":"171","author":"Balenga","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0025","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/cr.2011.60","article-title":"GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils","volume":"21","author":"Balenga","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.phrs.2016.06.012_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0035","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.06.012_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.prostaglandins.2009.04.006","article-title":"Orphan endogenous lipids and orphan GPCRs: a good match","volume":"89","author":"Bradshaw","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.phrs.2016.06.012_bib0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2013.03.003","article-title":"Targeting TRP channels for pain relief","volume":"716","author":"Brederson","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10790268.2007.11753405","article-title":"Pain after spinal cord injury: an evidence-based review for clinical practice and research: report of the National Institute on Disability and Rehabilitation Research Spinal Cord Injury Measures meeting","volume":"30","author":"Bryce","year":"2007","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.phrs.2016.06.012_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","article-title":"Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide","volume":"419","author":"Calignano","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0304-3959(88)90027-9","article-title":"Myelinated afferents signal the hyperalgesia associated with nerve injury","volume":"32","author":"Campbell","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.06.012_bib0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.06.012_bib0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.bjp.0706699","article-title":"Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms","volume":"148","author":"Chang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/bjp.2008.100","article-title":"Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction","volume":"154","author":"Christie","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2015.04.007","article-title":"Differential upregulation of the cannabinoid CB\u2fff receptor in neurotoxic and inflammation-driven rat models of Parkinson\u2fffs disease","volume":"269","author":"Concannon","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.phrs.2010.02.001","article-title":"The dual fatty acid amide hydrolase\/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice","volume":"61","author":"Costa","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.06.012_bib0095","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pain.2008.06.003","article-title":"The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors","volume":"139","author":"Costa","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1096\/fj.05-4943fje","article-title":"Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation","volume":"20","author":"D\u2fffArgenio","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.06.012_bib0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35012076","article-title":"Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia","volume":"405","author":"Davis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.06.012_bib0110","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neuropharm.2008.06.023","article-title":"The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats","volume":"55","author":"De Novellis","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.06.012_bib0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bjp.0705333","article-title":"Manipulation of the endocannabinoid system by a general anaesthetic","volume":"139","author":"Di Marzo","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0120","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.4833-06.2007","article-title":"The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation","volume":"27","author":"Gavva","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"Gavva","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0130","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/cercor\/bhr328","article-title":"TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception","volume":"22","author":"Giordano","year":"2012","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.phrs.2016.06.012_bib0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","article-title":"Receptors for acylethanolamides-GPR55 and GPR119","volume":"89","author":"Godlewski","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.phrs.2016.06.012_bib0140","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00204-013-1051-3","article-title":"Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells","volume":"87","author":"Gustafsson","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0145","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"Entourage effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"[30].Ho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2004.07.028","article-title":"TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia","volume":"500","author":"Holzer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.anclin.2007.07.010","article-title":"The diagnostic workup of patients with neuropathic pain","volume":"25","author":"Horowitz","year":"2007","journal-title":"Anesthesiol. Clin."},{"key":"10.1016\/j.phrs.2016.06.012_bib0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pain.2007.04.032","article-title":"The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level","volume":"134","author":"Horvath","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0165","doi-asserted-by":"crossref","first-page":"42639","DOI":"10.1074\/jbc.M107351200","article-title":"Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.06.012_bib0170","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pain.2005.12.018","article-title":"CB2 cannabinoid receptor mediation of antinociception","volume":"122","author":"Ibrahim","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0185","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1476-5381.2010.00935.x","article-title":"N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn","volume":"161","author":"Jeong","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0190","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.bjp.0704199","article-title":"Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide","volume":"133","author":"Jonsson","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0195","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/glia.22560","article-title":"The G protein-coupled receptor 55 ligand l-\u03b1-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion","volume":"61","author":"Kallendrusch","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2016.06.012_bib0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(01)01059-7","article-title":"Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice","volume":"422","author":"Kamei","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0205","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuron.2013.12.011","article-title":"Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain","volume":"81","author":"Kim","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2016.06.012_bib0210","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.06.012_bib0215","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2006.06.175","article-title":"Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18","volume":"347","author":"Kohno","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2016.06.012_bib0220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14779072.2.2.265","article-title":"Cardiovascular effects of selective cyclooxygenase-2 inhibitors","volume":"2","author":"Krum","year":"2004","journal-title":"Exp. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2016.06.012_bib0225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neuropharm.2015.10.003","article-title":"Opioids and TRPV1 in the peripheral control of neuropathic pain\u2fffdefining a target site in the injured nerve","volume":"101","author":"Labuz","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.06.012_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2009.09.021","article-title":"1-(2\u2ff2,4\u2ff2-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice","volume":"37","author":"Luongo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.06.012_bib0240","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","volume":"316","author":"Maione","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.06.012_bib0245","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.bjp.0707145","article-title":"Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors","volume":"150","author":"Maione","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0250","doi-asserted-by":"crossref","first-page":"686908","DOI":"10.1155\/2014\/686908","article-title":"Alterations in the anandamide metabolism in the development of neuropathic pain","volume":"2014","author":"Malek","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phrs.2016.06.012_bib0255","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/j.pain.0000000000000132","article-title":"A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis","volume":"156","author":"Malek","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0260","doi-asserted-by":"crossref","first-page":"130639","DOI":"10.1155\/2015\/130639","article-title":"Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures","volume":"2015","author":"Malek","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.phrs.2016.06.012_bib0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0270","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.06.012_bib0275","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1016\/j.bmcl.2009.09.033","article-title":"Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands","volume":"19","author":"Morera","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2016.06.012_bib0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00230014","article-title":"Further evidence for myelinated as well as unmyelinated fibre damage in a rat model of neuropathic pain","volume":"91","author":"Nuytten","year":"1992","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.phrs.2016.06.012_bib0285","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1021\/jm070678q","article-title":"New N-arachidonoylserotonin analogues with potential dual mechanism of action against pain","volume":"50","author":"Ortar","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.06.012_bib0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pain.2008.03.017","article-title":"Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain","volume":"139","author":"Osikowicz","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog","volume":"50","author":"Pacher","year":"2011","journal-title":"Lipid Res."},{"key":"10.1016\/j.phrs.2016.06.012_bib0300","doi-asserted-by":"crossref","first-page":"e24034","DOI":"10.1371\/journal.pone.0024034","article-title":"Cannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases","volume":"6","author":"Paszcuk","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.012_bib0305","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","article-title":"Pharmacology of cannabinoid receptor ligands","volume":"6","author":"Pertwee","year":"1999","journal-title":"Curr. Med. Chem."},{"issue":"Pt 3","key":"10.1016\/j.phrs.2016.06.012_bib0310","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1469-7793.1999.0721p.x","article-title":"A study of the voltage dependence of capsaicin-activated membrane currents in rat sensory neurones before and after acute desensitization","volume":"518","author":"Piper","year":"1999","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.phrs.2016.06.012_bib0315","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/cn300015x","article-title":"Redundancy of endocannabinoid inactivation: new challenges and opportunities for pain control","volume":"3","author":"Piscitelli","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0320","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","article-title":"Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tvjl.2005.10.003","article-title":"Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals","volume":"173","author":"Re","year":"2007","journal-title":"Vet. J."},{"key":"10.1016\/j.phrs.2016.06.012_bib0330","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/ALN.0b013e318167af74","article-title":"Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury","volume":"108","author":"Romero-Sandoval","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2016.06.012_bib0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/JPR.S26603","article-title":"Dorsal root ganglion\u2fff a potential new therapeutic target for neuropathic pain","volume":"5","author":"Sapunar","year":"2012","journal-title":"J. Pain Res."},{"key":"10.1016\/j.phrs.2016.06.012_bib0340","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neurobiolaging.2014.09.019","article-title":"Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer\u2fffs disease mouse model","volume":"36","author":"Schm\u00f6le","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2016.06.012_bib0345","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/jpet.102.040394","article-title":"Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin","volume":"303","author":"Seabrook","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.06.012_bib0350","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.05.026","article-title":"New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy","volume":"85","author":"Shaqura","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.06.012_bib0355","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature05285","article-title":"Spider toxins activate the capsaicin receptor to produce inflammatory pain","volume":"444","author":"Siemens","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.06.012_bib0360","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12035-013-8487-6","article-title":"Glia and mast cells as targets for palmitoylethanolamide: an anti-inflammatory and neuroprotective lipid mediator","volume":"48","author":"Skaper","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0365","doi-asserted-by":"crossref","first-page":"13739","DOI":"10.1523\/JNEUROSCI.3258-07.2007","article-title":"Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways","volume":"27","author":"Starowicz","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0370","doi-asserted-by":"crossref","first-page":"e60040","DOI":"10.1371\/journal.pone.0060040","article-title":"Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism","volume":"8","author":"Starowicz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.06.012_bib0375","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1098\/rstb.2011.0392","article-title":"Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid\/endovanilloid system","volume":"367","author":"Starowicz","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","article-title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","volume":"139","author":"Staton","year":"2008","journal-title":"Pain"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2016.06.012_bib0385","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","volume":"56","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.06.012_bib0390","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","article-title":"The cloned capsaicin receptor integrates multiple pain-producing stimuli","volume":"21","author":"Tominaga","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2016.06.012_bib0395","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/ALN.0000000000000422","article-title":"Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury","volume":"121","author":"Ueda","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2016.06.012_bib0400","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.pain.2013.02.007","article-title":"Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models","volume":"154","author":"Vincenzi","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0405","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.102.042010","article-title":"The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain","volume":"304","author":"Walker","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.06.012_bib0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.01.057","article-title":"Activated microglia in the spinal cord underlies diabetic neuropathic pain","volume":"728","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0415","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.physbeh.2015.01.038","article-title":"Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish","volume":"142","author":"Wolkers","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2016.06.012_bib0420","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2016.06.012_bib0425","article-title":"GPR55\u2fffa putative type 3 cannabinoid receptor in inflammation","author":"Yang","year":"2015","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.06.012_bib0430","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1460-9568.2009.07075.x","article-title":"Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization","volume":"31","author":"Zhang","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0435","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.06.012_bib0440","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-6606-4-31","article-title":"Neuronal and microglial mechanisms of neuropathic pain","volume":"4","author":"Zhuo","year":"2011","journal-title":"Mol. Brain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0445","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.06.012_bib0450","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:40:58Z","timestamp":1657240858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816305667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":90,"alternative-id":["S1043661816305667"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.06.012","relation":{},"ISSN":["1043-6618"],"issn-type":[{"type":"print","value":"1043-6618"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}